1449756-87-9

1449756-87-9 structure

Name: HCV-IN-7 hydrochloride
Chemical Name: HCV-IN-7 hydrochloride
CAS Number: 1449756-87-9
Molecular Formula: C₄₀H₅₀Cl₂N₈O₆S
Molecular Weight: 841.85
Catalog: Signaling Pathways Anti-infection HCV
Create Date: 2020-01-23 20:50:51
Modify Date: 2025-09-04 13:38:10
HCV-IN-7 hydrochloride is an orally active and potent pan-genotypic HCV NS5A inhibitor with IC50s of 3-47 pM. HCV-IN-7 hydrochloride shows a superior pan-genotypic profile and a good pharmacokinetic profile coupled with a favorable liver uptake. HCV-IN-7 hydrochloride has anti-viral activity[1].

Name	HCV-IN-7 hydrochloride

Description	HCV-IN-7 hydrochloride is an orally active and potent pan-genotypic HCV NS5A inhibitor with IC50s of 3-47 pM. HCV-IN-7 hydrochloride shows a superior pan-genotypic profile and a good pharmacokinetic profile coupled with a favorable liver uptake. HCV-IN-7 hydrochloride has anti-viral activity[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Anti-infection >> HCV
Target	IC50: 3-47 pM (genotypic HCV NS5A)[1]
In Vitro	HCV-IN-7 hydrochloride inhibits GT1b (IC50=12 pM), GT2a (IC50=5 pM), GT1a (IC50=27 pM), GT3a (IC50=47 pM), GT4a (IC50=3 pM), GT6a (IC50=28 pM)[1]. HCV-IN-7 hydrochloride (10 µM) has 12%, 42%, 12% inhibition for CYP2D6, CYP2C9, CYP3A4, respectively[1]. HCV-IN-7 hydrochloride (10 µM) has cytotoxicity of 14%, 22%, 36% in Huh7, HepG2 and HEK cells, respectively[1]. HCV-IN-7 hydrochloride has a less complex central tricyclic core as novel and potent pan-genotypic NS5A inhibitors with good pharmacokinetic profile[1].
In Vivo	HCV-IN-7 hydrochloride (iv; 1 mg/kg) has a T1/2 of 2 hours, CL of 11 mL/min/kg, and a Vss of 2 L/kg for rats[1]. HCV-IN-7 hydrochloride (po; 10 mg/kg) has a Cmax of 1 μM and an AUClast of 6 μM for rats[1]. HCV-IN-7 hydrochloride (iv; 1 mg/kg) has a T1/2 of 4 hours, CL of 6 mL/min/kg, and a Vss of 2 L/kg for dog[1]. HCV-IN-7 hydrochloride (po; 10 mg/kg) has a Cmax of 5 μM and an AUClast of 49 μM for dog[1].
References	[1]. Ramdas V, et al. Discovery and Characterization of Potent Pan-Genotypic HCV NS5A Inhibitors Containing Novel Tricyclic Central Core Leading to Clinical Candidate. J Med Chem. 2019 Dec 12;62(23):10563-10582.

Molecular Formula	C₄₀H₅₀Cl₂N₈O₆S
Molecular Weight	841.85

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

1449756-87-9	1449756-86-8
1009119-83-8	2058080-25-2
2425804-98-2	2757963-82-7
1998705-62-6	2757963-83-8
1007882-23-6	1401839-25-5
941988-24-5	941951-53-7
941908-67-4	941902-31-4
941951-84-4	941908-94-7
941988-63-2	941902-61-0
941951-86-6	941902-70-1